Sign in
DGEN Stock Price, Chart, Stats & News
Deltagen Inc.
Save
Deltagen Inc. (DGEN) does not currently pay a dividend.
3,859
Market cap
–
Current P/E
21.93x
Forward P/E
DGEN chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Instruments & Supplies
Industry
Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases.
Similar securities
Based on sector and market capitalization
Report issue